Status:

UNKNOWN

Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be Replaced by Whipple Over the Splenic Artery: A Before and After Study

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Ductal Adenocarcinoma of the Pancreas

Eligibility:

All Genders

20+ years

Brief Summary

Recently, more and more total pancreatectomy (TP) has been performed for pancreatic ductal cell adenocarcinoma (PDCA) which abuts or involves both gastroduodenal and splenic arteries. Warshaw's proced...

Detailed Description

Recently, more and more total pancreatectomy (TP) has been performed for pancreatic ductal cell adenocarcinoma (PDCA) which abuts or involves both gastroduodenal and splenic arteries. Warshaw's proced...

Eligibility Criteria

Inclusion

  • pancreatic ductal cell adenocarcinoma (PDCA) patients

Exclusion

  • Patient undergoing palliative pancreatectomy, other malignancies with distant metastases
  • Vulnerable groups

Key Trial Info

Start Date :

May 20 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 20 2025

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT06119776

Start Date

May 20 2020

End Date

May 20 2025

Last Update

November 7 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Taiwan University Hospital

Taipei, Taiwan